<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="23ab5537-5d5b-41d6-618c-974930319a48"><labelDrug name="Dutoprol"><Normalization><mmtx cui="C3264879" preferredWord="Dutoprol" semType="phsu, orch"/></Normalization></labelDrug><generic name="metoprolol succinate and hydrochlorothiazide"/><sentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.1" text="DUTOPROL (metoprolol succinate and hydrochlorothiazide) tablet, film coated" type="negative"><entity charOffset="10:30" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.1.e.0" text="metoprolol succinate" type="Biomedical_Entity"><Normalization><mmtx cui="C0724633" phraseText="(metoprolol succinate" preferredWord="metoprolol succinate" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><entity charOffset="35:54" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.1.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="0:8" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.1.e.2" text="dutoprol" type="Biomedical_Entity"><Normalization><mmtx cui="C3264879" phraseText="DUTOPROL" preferredWord="Dutoprol" semType="phsu, orch"/><RxNorm RxCui="1372709"/></Normalization></entity><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.1.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.1.e.1"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.1.e.2" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.1.e.0"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.1.e.2" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.1.e.1"/></sentence><sentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2" text="DUTOPROL (metoprolol succinate extended release/hydrochlorothiazide) combines a beta1-selective (cardioselective) adrenoceptor blocking agent and a diuretic, hydrochlorothiaz." type="negative"><entity charOffset="10:30" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.0" text="metoprolol succinate" type="Biomedical_Entity"><Normalization><mmtx cui="C0724633" phraseText="(metoprolol succinate extended release/hydrochlorothiazide" preferredWord="metoprolol succinate" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><entity charOffset="148:156" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.1" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="a diuretic, hydrochlorothiaz." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="0:8" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.2" text="dutoprol" type="Biomedical_Entity"><Normalization><mmtx cui="C3264879" phraseText="DUTOPROL" preferredWord="Dutoprol" semType="phsu, orch"/><RxNorm RxCui="1372709"/></Normalization></entity><entity charOffset="48:67" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.3" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="(metoprolol succinate extended release/hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="10:67" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.4" text="metoprolol hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0717827" phraseText="(metoprolol succinate extended release/hydrochlorothiazide" preferredWord="Hydrochlorothiazide / Metoprolol" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><entity charOffset="21:30" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.5" text="succinate" type="Biomedical_Entity"><Normalization><mmtx cui="C0220918" phraseText="(metoprolol succinate extended release/hydrochlorothiazide" preferredWord="succinate" semType="phsu, orch"/><RxNorm RxCui="1307106"/></Normalization></entity><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.1"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.2" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.0"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.3"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.4" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.0"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.5"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.2" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.1"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.3" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.1"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.4" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.1"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.5" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.1"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.2" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.3"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.2" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.4"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.2" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.5"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.4" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.3"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.5" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.3"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.4" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.2.e.5"/></sentence><sentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.4" text="Metoprolol succinate extended release/hydrochlorothiazide is contraindicated in patients in cardiogenic shock, overt cardiac failure (see WARNINGS), second or third degree AV block, marked sinus bradycardia, anuria, and hypersensitivity to either component of this product or to other sulfonamide-derived drugs." type="negative"><entity charOffset="285:296" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.4.e.0" text="sulfonamide" type="Biomedical_Entity"><Normalization><mmtx cui="C3536763" phraseText="or to other sulfonamide-derived drugs." preferredWord="Sulfonamide [EPC]" semType="phsu"/><RxNorm RxCui="1427600"/></Normalization></entity><entity charOffset="11:20" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.4.e.1" text="succinate" type="Biomedical_Entity"><Normalization><mmtx cui="C0220918" phraseText="Metoprolol succinate extended release/hydrochlorothiazide" preferredWord="succinate" semType="phsu, orch"/><RxNorm RxCui="1307106"/></Normalization></entity><entity charOffset="0:57" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.4.e.2" text="metoprolol hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0717827" phraseText="Metoprolol succinate extended release/hydrochlorothiazide" preferredWord="Hydrochlorothiazide / Metoprolol" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><entity charOffset="38:57" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.4.e.3" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Metoprolol succinate extended release/hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="0:20" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.4.e.4" text="metoprolol succinate" type="Biomedical_Entity"><Normalization><mmtx cui="C0724633" phraseText="Metoprolol succinate extended release/hydrochlorothiazide" preferredWord="metoprolol succinate" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.4.e.1" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.4.e.0"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.4.e.2" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.4.e.0"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.4.e.3" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.4.e.0"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.4.e.4" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.4.e.0"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.4.e.2" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.4.e.1"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.4.e.1" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.4.e.3"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.4.e.4" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.4.e.1"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.4.e.2" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.4.e.3"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.4.e.4" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.4.e.2"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.4.e.4" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.4.e.3"/></sentence><sentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.13" text="Because of its relative beta1 cardio-selectivity, however, metoprolol succinate extended release/hydrochlorothiazide may be used in patients with bronchospastic disease who do not respond to, or cannot tolerate, other antihypertensive treatment. " type="negative"><entity charOffset="59:79" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.13.e.0" text="metoprolol succinate" type="Biomedical_Entity"><Normalization><mmtx cui="C0724633" phraseText="metoprolol succinate extended release/hydrochlorothiazide" preferredWord="metoprolol succinate" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><entity charOffset="218:234" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.13.e.1" text="antihypertensive" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="other antihypertensive treatment." preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="59:116" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.13.e.2" text="metoprolol hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0717827" phraseText="metoprolol succinate extended release/hydrochlorothiazide" preferredWord="Hydrochlorothiazide / Metoprolol" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><entity charOffset="97:116" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.13.e.3" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="metoprolol succinate extended release/hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="70:79" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.13.e.4" text="succinate" type="Biomedical_Entity"><Normalization><mmtx cui="C0220918" phraseText="metoprolol succinate extended release/hydrochlorothiazide" preferredWord="succinate" semType="phsu, orch"/><RxNorm RxCui="1307106"/></Normalization></entity><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.13.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.13.e.1"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.13.e.2" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.13.e.0"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.13.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.13.e.3"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.13.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.13.e.4"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.13.e.2" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.13.e.1"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.13.e.3" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.13.e.1"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.13.e.4" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.13.e.1"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.13.e.2" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.13.e.3"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.13.e.2" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.13.e.4"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.13.e.4" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.13.e.3"/></sentence><sentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.15" text="Bronchodilators, including beta2 agonists, should be readily available or administered concomitantly (see DOSAGE AND ADMINISTRATION)." type="negative"><entity charOffset="33:41" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.15.e.0" text="agonists" type="Biomedical_Entity"><Normalization><mmtx cui="C2987634" phraseText="beta2 agonists," preferredWord="Agonist" semType="phsu"/><RxNorm RxCui="608609"/></Normalization></entity><entity charOffset="0:15" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.15.e.1" text="bronchodilators" type="Biomedical_Entity"><Normalization><mmtx cui="C0006280" phraseText="Bronchodilators," preferredWord="Bronchodilator Agents" semType="phsu"/><RxNorm RxCui="1779"/></Normalization></entity><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.15.e.1" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.15.e.0"/></sentence><sentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.16" text="Pheochromocytoma: If DUTOPROL is used in the setting of pheochromocytoma, it should be given in combination with an alpha blocker, and only after the alpha blocker has been initiated. " type="negative"><entity charOffset="116:129" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.16.e.0" text="alpha blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0001641" phraseText="with an alpha blocker," preferredWord="Adrenergic alpha-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="150:163" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.16.e.1" text="alpha blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0001641" phraseText="only after the alpha blocker" preferredWord="Adrenergic alpha-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="21:29" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.16.e.2" text="dutoprol" type="Biomedical_Entity"><Normalization><mmtx cui="C3264879" phraseText="DUTOPROL" preferredWord="Dutoprol" semType="phsu, orch"/><RxNorm RxCui="1372709"/></Normalization></entity><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.16.e.2" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.16.e.0"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.16.e.2" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.16.e.1"/></sentence><sentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.17" text="Administration of beta-blockers alone in the setting of pheochromocytoma has been associated with a paradoxical increase in blood pressure due to the attenuation of beta-mediated vasodilatation in skeletal muscle." type="negative"><entity charOffset="170:178" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.17.e.0" text="mediated" type="Biomedical_Entity"><Normalization><mmtx cui="C0127400" phraseText="of beta-mediated vasodilatation" preferredWord="Mediator brand of benfluorex hydrochloride" semType="phsu, orch"/><RxNorm RxCui="985488"/></Normalization></entity><entity charOffset="18:31" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.17.e.1" text="beta-blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="Administration of beta-blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.17.e.1" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.17.e.0"/></sentence><sentence biomedicalEntities="4" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.25" lineNumber="29" text="Calcium Channel Blockers: Because of significant inotropic and chronotropic effects in patients treated with beta-blockers and calcium channel blockers of the verapamil and diltiazem type, caution should be exercised in patients treated with these agents concomitantly." type="regular"><entity charOffset="189:196" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.25.e.0" text="caution" type="Caution_Interaction"/><entity charOffset="109:122" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.25.e.2" text="beta-blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="treated with beta-blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="127:151" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.25.e.3" text="calcium channel blockers" type="Drug_Class"><Normalization><mmtx cui="C0006684" phraseText="calcium channel blockers of the verapamil" preferredWord="Calcium Channel Blockers" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="159:168" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.25.e.4" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="calcium channel blockers of the verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="173:182" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.25.e.5" text="diltiazem" type="Drug"><Normalization><mmtx cui="C0012373" phraseText="diltiazem type," preferredWord="Diltiazem" semType="phsu, orch"/><RxNorm RxCui="203211"/></Normalization></entity><drugClassMembership drug="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.25.e.5" drugClass="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.25.e.3"/><drugClassMembership drug="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.25.e.4" drugClass="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.25.e.3"/><drugInteraction id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.25.ddi.1"><interaction trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.25.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.25.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.25.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.25.e.2" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.25.e.3" trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.25.e.0" type="Caution_Interaction"/></sentence><sentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.27" text="Acute Myopia and Secondary Angle-Closure Glaucoma: Hydrochlorothiazide, a sulfonamide, can cause an idiosyncratic reaction, resulting in acute transient myopia and acute angle-closure glaucoma. " type="negative"><entity charOffset="51:70" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.27.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Hydrochlorothiazide," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="74:85" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.27.e.1" text="sulfonamide" type="Biomedical_Entity"><Normalization><mmtx cui="C3536763" phraseText="a sulfonamide," preferredWord="Sulfonamide [EPC]" semType="phsu"/><RxNorm RxCui="1427600"/></Normalization></entity><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.27.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.27.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.41" lineNumber="43" text="Lithium Interaction: Lithium generally should not be given with thiazides (see PRECAUTIONS, Drug Interactions, Hydrochlorothiazide, Lithium)." type="regular"><entity charOffset="21:28" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.41.e.0" text="Lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="Lithium generally" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="64:73" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.41.e.1" text="thiazides" type="Drug_Class"><Normalization><mmtx cui="C0541746" phraseText="given with thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="46:58" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.41.e.2" text="not be given" type="Caution_Interaction"/><drugInteraction id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.41.ddi.1"><interaction trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.41.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.41.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.41.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.41.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.41.e.1" trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.41.e.2" type="Caution_Interaction"/></sentence><sentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.44" text="Metoprolol succinate extended release/hydrochlorothiazide" type="negative"><entity charOffset="11:20" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.44.e.0" text="succinate" type="Biomedical_Entity"><Normalization><mmtx cui="C0220918" phraseText="Metoprolol succinate extended release/hydrochlorothiazide" preferredWord="succinate" semType="phsu, orch"/><RxNorm RxCui="1307106"/></Normalization></entity><entity charOffset="0:57" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.44.e.1" text="metoprolol hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0717827" phraseText="Metoprolol succinate extended release/hydrochlorothiazide" preferredWord="Hydrochlorothiazide / Metoprolol" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><entity charOffset="38:57" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.44.e.2" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Metoprolol succinate extended release/hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="0:20" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.44.e.3" text="metoprolol succinate" type="Biomedical_Entity"><Normalization><mmtx cui="C0724633" phraseText="Metoprolol succinate extended release/hydrochlorothiazide" preferredWord="metoprolol succinate" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.44.e.1" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.44.e.0"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.44.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.44.e.2"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.44.e.3" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.44.e.0"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.44.e.1" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.44.e.2"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.44.e.3" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.44.e.1"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.44.e.3" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.44.e.2"/></sentence><sentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.45" text="The precautions for the use of metoprolol succinate extended release/hydrochlorothiazide are the same as for the individual agents." type="negative"><entity charOffset="42:51" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.45.e.0" text="succinate" type="Biomedical_Entity"><Normalization><mmtx cui="C0220918" phraseText="The precautions for the use of metoprolol succinate extended release/hydrochlorothiazide" preferredWord="succinate" semType="phsu, orch"/><RxNorm RxCui="1307106"/></Normalization></entity><entity charOffset="69:88" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.45.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="The precautions for the use of metoprolol succinate extended release/hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="31:88" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.45.e.2" text="metoprolol hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0717827" phraseText="The precautions for the use of metoprolol succinate extended release/hydrochlorothiazide" preferredWord="Hydrochlorothiazide / Metoprolol" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><entity charOffset="31:51" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.45.e.3" text="metoprolol succinate" type="Biomedical_Entity"><Normalization><mmtx cui="C0724633" phraseText="The precautions for the use of metoprolol succinate extended release/hydrochlorothiazide" preferredWord="metoprolol succinate" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.45.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.45.e.1"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.45.e.2" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.45.e.0"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.45.e.3" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.45.e.0"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.45.e.2" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.45.e.1"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.45.e.3" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.45.e.1"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.45.e.3" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.45.e.2"/></sentence><sentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.50" text="If such symptoms occur, diuretics should be increased and the dose of beta-blocking agent should not be advanced until clinical stability is restored. " type="negative"><entity charOffset="70:89" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.50.e.0" text="beta-blocking agent" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="the dose of beta-blocking agent" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="24:33" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.50.e.1" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="diuretics" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.50.e.1" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.50.e.0"/></sentence><sentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.55" text="Periodic determination of serum electrolytes to detect possible electrolyte imbalance should be performed at appropriate intervals." type="negative"><entity charOffset="32:44" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.55.e.0" text="electrolytes" type="Biomedical_Entity"><Normalization><mmtx cui="C3536863" phraseText="Periodic determination of serum electrolytes to" preferredWord="Electrolyte [EPC]" semType="phsu"/><RxNorm RxCui="3793"/></Normalization></entity><entity charOffset="64:75" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.55.e.1" text="electrolyte" type="Biomedical_Entity"><Normalization><mmtx cui="C0013832" phraseText="possible electrolyte imbalance" preferredWord="Electrolytes" semType="inch, phsu"/><RxNorm RxCui="3793"/></Normalization></entity><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.55.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.55.e.1"/></sentence><sentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.56" text="All patients receiving thiazide therapy should be observed for clinical signs of fluid or electrolyte imbalance: namely, hyponatremia, hypochloremic alkalosis, and hypokalemia. " type="negative"><entity charOffset="90:101" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.56.e.0" text="electrolyte" type="Biomedical_Entity"><Normalization><mmtx cui="C3536863" phraseText="electrolyte imbalance" preferredWord="Electrolyte [EPC]" semType="phsu"/><RxNorm RxCui="3793"/></Normalization></entity><entity charOffset="23:31" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.56.e.1" text="thiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="thiazide therapy" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.56.e.1" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.56.e.0"/></sentence><sentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.62" text="Hypokalemia may be avoided or treated by use of potassium sparing diuretics or potassium supplements such as foods with a high potassium content. " type="negative"><entity charOffset="79:88" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.62.e.0" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="potassium" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="127:136" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.62.e.1" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="with a high potassium content." preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="48:75" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.62.e.2" text="potassium sparing diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0304490" phraseText="treated by use of potassium sparing diuretics" preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="8588"/></Normalization></entity><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.62.e.2" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.62.e.0"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.62.e.2" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.62.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.68" lineNumber="71" text="In diabetic patients dosage adjustments of insulin or oral hypoglycemic agents may be required. " type="irregular"><entity charOffset="21:39" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.68.e.0" text="dosage adjustments" type="Caution_Interaction"/><entity charOffset="43:50" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.68.e.2" text="insulin" type="Drug"><Normalization><mmtx cui="C0021641" phraseText="of insulin" preferredWord="Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1533581" phraseText="of insulin" preferredWord="Recombinant Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1579433" phraseText="of insulin" preferredWord="Insulin [EPC]" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="54:78" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.68.e.3" text="oral hypoglycemic agents" type="Drug_Class"><Normalization><mmtx cui="C0359086" phraseText="oral hypoglycemic agents" preferredWord="Oral hypoglycemic" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="3:20" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.68.e.4" text="diabetic patients" type="SPAN"/><drugInteraction id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.68.ddi.1"><interaction trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.68.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.54" text="Hydrochlorothiazide"><entity charOffset="0:19" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.54.e.0" text="Hydrochlorothiazide" type="Drug"><Normalization><mmtx cui="C0020261" phraseText="Hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.55" text="Periodic determination of serum electrolytes to detect possible electrolyte imbalance should be performed at appropriate intervals."/><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.56" text="All patients receiving thiazide therapy should be observed for clinical signs of fluid or electrolyte imbalance: namely, hyponatremia, hypochloremic alkalosis, and hypokalemia. "/><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.57" text="Serum and urine electrolyte determinations are particularly important when the patient is vomiting excessively or receiving parenteral fluids. "/><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.58" text="Warning signs or symptoms of fluid and electrolyte imbalance, irrespective of cause, include dryness of mouth, thirst, weakness, lethargy, drowsiness, restlessness, confusion, seizures, muscle pains or cramps, muscular fatigue, hypotension, oliguria, tachycardia, and gastrointestinal disturbances such as nausea and vomiting."/><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.59" text="Hypokalemia may develop, especially with brisk diuresis, when severe cirrhosis is present, or after prolonged therapy. "/><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.60" text="Interference with adequate oral electrolyte intake will also contribute to hypokalemia. "/><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.61" text="Hypokalemia may cause cardiac arrhythmia and may also sensitize or exaggerate the response of the heart to the toxic effects of digitalis (eg, increased ventricular irritability). "/><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.62" text="Hypokalemia may be avoided or treated by use of potassium sparing diuretics or potassium supplements such as foods with a high potassium content. "/><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.63" text="Although any chloride deficit is generally mild and usually does not require specific treatment, except under extraordinary circumstances (as in liver disease or renal disease), chloride replacement may be required in the treatment of metabolic alkalosis."/><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.64" text="Dilutional hyponatremia may occur in edematous patients in hot weather; "/><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.65" text="appropriate therapy is water restriction, rather than administration of salt, except in rare instances when the hyponatremia is life threatening. "/><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.66" text="In actual salt depletion, appropriate replacement is the therapy of choice."/><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.67" text="Hyperuricemia may occur or acute gout may be precipitated in certain patients receiving thiazide therapy."/></relation><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.68.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.68.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.68.e.4"/></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.75" text="Thiazides may decrease urinary calcium excretion. " type="negative"><entity charOffset="0:9" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.75.e.0" text="thiazides" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="Thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="31:38" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.75.e.1" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C2936886" phraseText="urinary calcium excretion." preferredWord="Calcium [EPC]" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.75.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.75.e.1"/></sentence><sentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.76" text="Thiazides may cause intermittent and slight elevation of serum calcium in the absence of known disorders of calcium metabolism. " type="negative"><entity charOffset="0:9" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.76.e.0" text="thiazides" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="Thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="63:70" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.76.e.1" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C0006675" phraseText="slight elevation of serum calcium" preferredWord="Calcium" semType="bacs, phsu, elii"/><RxNorm RxCui="1895"/></Normalization></entity><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.76.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.76.e.1"/></sentence><sentence biomedicalEntities="4" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.82" lineNumber="87" text="Catecholamine-depleting drugs (eg, reserpine, monoamine oxidase (MAO) inhibitors) may have an additive effect when given with beta-blocking agents. " type="regular"><entity charOffset="0:29" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.82.e.0" text="Catecholamine-depleting drugs" type="Drug_Class"><Normalization><mmtx cui="C0007412" phraseText="Catecholamine-depleting drugs" preferredWord="Catecholamines" semType="phsu, nsba"/><mmtx cui="C0013227" phraseText="Catecholamine-depleting drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><mmtx cui="C3536742" phraseText="Catecholamine-depleting drugs" preferredWord="Catecholamine [EPC]" semType="phsu"/><mmtx cui="C0013227" phraseText="Catecholamine-depleting drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="990350"/></Normalization></entity><entity charOffset="35:44" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.82.e.1" text="reserpine" type="Drug"><Normalization><mmtx cui="C0035179" phraseText="reserpine," preferredWord="Reserpine" semType="phsu, orch"/><RxNorm RxCui="9260"/></Normalization></entity><entity charOffset="46:80" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.82.e.2" text="monoamine oxidase (MAO) inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0026457" phraseText="monoamine oxidase (MAO) inhibitors" preferredWord="Monoamine Oxidase Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1565"/></Normalization></entity><entity charOffset="126:146" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.82.e.5" text="beta-blocking agents" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="given with beta-blocking agents." preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="86:109" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.82.e.6" text="have an additive effect" type="Increase_Interaction"/><drugClassMembership drug="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.82.e.1" drugClass="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.82.e.0"/><classClassMembership drugClass="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.82.e.2"/><drugInteraction id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.82.ddi.1"><interaction trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.82.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.82.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.82.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.82.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.82.e.5" trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.82.e.6" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.83" lineNumber="87" text="Observe patients treated with DUTOPROL plus a catecholamine depletor for evidence of hypotension or marked bradycardia, which may produce vertigo, syncope, or postural hypotension." type="regular"><entity charOffset="30:38" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.83.e.0" text="DUTOPROL" type="Drug"><Normalization><mmtx cui="C3264879" phraseText="treated with DUTOPROL" preferredWord="Dutoprol" semType="phsu, orch"/><RxNorm RxCui="1372709"/></Normalization></entity><entity charOffset="46:68" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.83.e.1" text="catecholamine depletor" type="Drug_Class"><Normalization><mmtx cui="C0007412" phraseText="plus a catecholamine depletor" preferredWord="Catecholamines" semType="phsu, nsba"/><mmtx cui="C3536742" phraseText="plus a catecholamine depletor" preferredWord="Catecholamine [EPC]" semType="phsu"/><RxNorm RxCui="1451215"/></Normalization></entity><entity charOffset="85:96" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.83.e.2" text="hypotension" type="Specific_Interaction"/><entity charOffset="107:118" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.83.e.4" text="bradycardia" type="Specific_Interaction"/><entity charOffset="138:145" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.83.e.6" text="vertigo" type="Specific_Interaction"><Normalization><mmtx cui="C0042571" phraseText="vertigo," preferredWord="Vertigo" semType="sosy"/></Normalization></entity><entity charOffset="147:154" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.83.e.8" text="syncope" type="Specific_Interaction"><Normalization><mmtx cui="C0039070" phraseText="syncope," preferredWord="Syncope" semType="sosy"/></Normalization></entity><entity charOffset="159:179" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.83.e.10" text="postural hypotension" type="Specific_Interaction"/><drugInteraction id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.83.ddi.1"><interaction trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.83.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.83.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.83.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.83.ddi.2"><interaction trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.83.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.83.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.83.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.83.ddi.3"><interaction trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.83.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.83.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.83.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.83.ddi.4"><interaction trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.83.e.8"><relations><relation type="hasPrecipitant"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.83.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.83.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.83.ddi.5"><interaction trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.83.e.10"><relations><relation type="hasPrecipitant"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.83.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.83.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.83.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.83.e.1" trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.83.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="6" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.84" lineNumber="89" text="Drugs that inhibit CYP2D6 such as quinidine, fluoxetine, paroxetine, and propafenone are likely to increase metoprolol concentration. " type="regular"><entity charOffset="0:25" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.84.e.0" text="Drugs that inhibit CYP2D6" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="Drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="34:43" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.84.e.1" text="quinidine" type="Drug"><Normalization><mmtx cui="C0034414" phraseText="CYP2D6 such as quinidine," preferredWord="Quinidine" semType="phsu, orch"/><RxNorm RxCui="9068"/></Normalization></entity><entity charOffset="45:55" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.84.e.2" text="fluoxetine" type="Drug"><Normalization><mmtx cui="C0016365" phraseText="fluoxetine," preferredWord="Fluoxetine" semType="phsu, orch"/><RxNorm RxCui="227224"/></Normalization></entity><entity charOffset="57:67" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.84.e.3" text="paroxetine" type="Drug"><Normalization><mmtx cui="C0070122" phraseText="paroxetine," preferredWord="Paroxetine" semType="phsu, orch"/><RxNorm RxCui="32937"/></Normalization></entity><entity charOffset="73:84" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.84.e.4" text="propafenone" type="Drug"><Normalization><mmtx cui="C0033429" phraseText="propafenone" preferredWord="Propafenone" semType="phsu, orch"/><RxNorm RxCui="8754"/></Normalization></entity><entity charOffset="108:118" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.84.e.5" text="metoprolol" type="Drug"><Normalization><mmtx cui="C0025859" phraseText="metoprolol concentration." preferredWord="Metoprolol" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><entity charOffset="99:107|119:132" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.84.e.10" text="increase concentration" type="Increase_Interaction"/><drugClassMembership drug="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.84.e.1" drugClass="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.84.e.0"/><drugClassMembership drug="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.84.e.2" drugClass="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.84.e.0"/><drugClassMembership drug="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.84.e.3" drugClass="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.84.e.0"/><drugClassMembership drug="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.84.e.4" drugClass="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.84.e.0"/><drugInteraction id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.84.ddi.1"><interaction trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.84.e.10"><relations><relation type="hasPrecipitant"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.84.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.84.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.84.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.84.e.5" trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.84.e.10" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.85" lineNumber="89" text="In healthy subjects with CYP2D6 extensive metabolizer phenotype, coadministration of quinidine 100 mg and immediate release metoprolol 200 mg tripled the concentration of S metoprolol and doubled the metoprolol elimination half life. " type="regular"><anaphoraRelation><anaphoraEntity charOffset="171:183" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.85.e.8" text="S—metoprolol" type="Drug"/><antecedentEntity charOffset="106-134" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.85.e.2" text="immediate release metoprolol" type="Drug"/></anaphoraRelation><anaphoraRelation><anaphoraEntity charOffset="200:210" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.85.e.7" text="metoprolol" type="Drug"/><antecedentEntity charOffset="106-134" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.85.e.2" text="immediate release metoprolol" type="Drug"/></anaphoraRelation><entity charOffset="25:63" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.85.e.0" text="CYP2D6 extensive metabolizer phenotype" type="SPAN"/><entity charOffset="85:94" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.85.e.1" text="quinidine" type="Drug"><Normalization><mmtx cui="C0034414" phraseText="coadministration of quinidine 100 mg" preferredWord="Quinidine" semType="phsu, orch"/><RxNorm RxCui="9068"/></Normalization></entity><entity charOffset="106:134" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.85.e.2" text="immediate release metoprolol" type="Drug"><Normalization><mmtx cui="C0025859" phraseText="immediate release metoprolol 200 mg" preferredWord="Metoprolol" semType="phsu, orch"/><RxNorm RxCui="1023968"/></Normalization></entity><entity charOffset="142:167" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.85.e.3" text="tripled the concentration" type="Increase_Interaction"/><entity charOffset="188:199|211:232" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.85.e.5" text="doubled the elimination half—life" type="Increase_Interaction"/><entity charOffset="200:210" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.85.e.7" text="metoprolol" type="Drug"><Normalization><mmtx cui="C0025859" phraseText="the metoprolol elimination half life." preferredWord="Metoprolol" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><entity charOffset="171:183" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.85.e.8" text="S—metoprolol" type="Drug"><Normalization><mmtx cui="C0025859" phraseText="the concentration of S metoprolol" preferredWord="Metoprolol" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><drugInteraction id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.85.ddi.1"><interaction trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.85.e.3"><relations><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.85.e.8"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.85.e.1"/></relation><relation type="hasContext"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.85.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.85.ddi.2"><interaction trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.85.e.5"><relations><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.85.e.7"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.85.e.1"/></relation><relation type="hasContext"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.85.e.0"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.85.e.0" ddi="true" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.85.e.1" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.85.e.8" trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.85.e.3" type="Increase_Interaction"/><pair context="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.85.e.0" ddi="true" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.85.e.1" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.85.e.7" trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.85.e.5" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.86" lineNumber="89" text="In four patients with cardiovascular disease, coadministration of propafenone 150 mg t.i.d. with immediate release metoprolol 50 mg t.i.d. resulted in two  to five-fold increases in the steady-state concentration of metoprolol. " type="regular"><anaphoraRelation><anaphoraEntity charOffset="216:226" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.86.e.4" text="metoprolol" type="Drug"/><antecedentEntity charOffset="97-125" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.86.e.1" text="immediate—release metoprolol" type="Drug"/></anaphoraRelation><entity charOffset="66:77" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.86.e.0" text="propafenone" type="Drug"><Normalization><mmtx cui="C0033429" phraseText="coadministration of propafenone 150 mg t.i.d." preferredWord="Propafenone" semType="phsu, orch"/><RxNorm RxCui="8754"/></Normalization></entity><entity charOffset="97:125" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.86.e.1" text="immediate—release metoprolol" type="Drug"><Normalization><mmtx cui="C0025859" phraseText="with immediate release metoprolol 50 mg t.i.d." preferredWord="Metoprolol" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="169:212" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.86.e.2" text="increases in the steady-state concentration" type="Increase_Interaction"/><entity charOffset="216:226" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.86.e.4" text="metoprolol" type="Drug"><Normalization><mmtx cui="C0025859" phraseText="increases in the steady-state concentration of metoprolol." preferredWord="Metoprolol" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><entity charOffset="22:44" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.86.e.6" text="cardiovascular disease" type="SPAN"><Normalization><mmtx cui="C0007222" phraseText="with cardiovascular disease," preferredWord="Cardiovascular Diseases" semType="dsyn"/></Normalization></entity><entity charOffset="3:16" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.86.e.7" text="four patients" type="SPAN"/><drugInteraction id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.86.ddi.1"><interaction trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.86.e.2"><relations><relation type="hasContext"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.86.e.6"/></relation><relation type="hasEvidence"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.86.e.7"/></relation><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.86.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.86.e.0"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.86.e.6" ddi="true" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.86.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.86.e.4" evidence="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.86.e.7" trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.86.e.2" type="Increase_Interaction"/></sentence><sentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.88" text="Digitalis glycosides, clonidine, diltiazem and verapamil slow atrioventricular conduction and decrease heart rate. " type="negative"><entity charOffset="22:31" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.88.e.0" text="clonidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0009014" phraseText="clonidine," preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="47:56" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.88.e.1" text="verapamil" type="Biomedical_Entity"><Normalization><mmtx cui="C0042523" phraseText="verapamil slow atrioventricular conduction" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="0:20" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.88.e.2" text="digitalis glycosides" type="Biomedical_Entity"><Normalization><mmtx cui="C0012253" phraseText="Digitalis glycosides," preferredWord="Digitalis Glycosides" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><entity charOffset="33:42" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.88.e.3" text="diltiazem" type="Biomedical_Entity"><Normalization><mmtx cui="C0012373" phraseText="diltiazem" preferredWord="Diltiazem" semType="phsu, orch"/><RxNorm RxCui="203211"/></Normalization></entity><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.88.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.88.e.1"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.88.e.2" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.88.e.0"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.88.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.88.e.3"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.88.e.2" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.88.e.1"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.88.e.3" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.88.e.1"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.88.e.2" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.88.e.3"/></sentence><sentence biomedicalEntities="1" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.89" lineNumber="91" text="Concomitant use with beta blockers can increase the risk of bradycardia." type="irregular"><entity charOffset="21:34" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.89.e.0" text="beta blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="Concomitant use with beta blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="60:71" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.89.e.1" text="bradycardia" type="Specific_Interaction"/><drugInteraction id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.89.ddi.1"><interaction trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.89.e.1"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.88" text="Digitalis glycosides, clonidine, diltiazem and verapamil slow atrioventricular conduction and decrease heart rate. "><entity charOffset="47:56" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.88.e.3" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="verapamil slow atrioventricular conduction" preferredWord="Verapamil" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.88" text="Digitalis glycosides, clonidine, diltiazem and verapamil slow atrioventricular conduction and decrease heart rate. "><entity charOffset="0:20" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.88.e.0" text="Digitalis glycosides" type="Drug_Class"><Normalization><mmtx cui="C0012253" phraseText="Digitalis glycosides," preferredWord="Digitalis Glycosides" semType="phsu, carb"/></Normalization></entity></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.88" text="Digitalis glycosides, clonidine, diltiazem and verapamil slow atrioventricular conduction and decrease heart rate. "><entity charOffset="22:31" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.88.e.1" text="clonidine" type="Drug"><Normalization><mmtx cui="C0009014" phraseText="clonidine," preferredWord="Clonidine" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.89.e.0"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.88" text="Digitalis glycosides, clonidine, diltiazem and verapamil slow atrioventricular conduction and decrease heart rate. "><entity charOffset="33:42" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.88.e.2" text="diltiazem" type="Drug"><Normalization><mmtx cui="C0012373" phraseText="diltiazem" preferredWord="Diltiazem" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="3" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.90" lineNumber="93" text="If clonidine and a beta blocker, such as metoprolol are coadministered, withdraw the beta-blocker several days before the gradual withdrawal of clonidine because beta-blockers may exacerbate the rebound hypertension that can follow the withdrawal of clonidine. " type="regular"><entity charOffset="19:31" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.90.e.0" text="beta blocker" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="a beta blocker," preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="41:51" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.90.e.1" text="metoprolol" type="Drug"><Normalization><mmtx cui="C0025859" phraseText="such as metoprolol" preferredWord="Metoprolol" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><entity charOffset="162:259" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.90.e.3" text="beta-blockers may exacerbate the rebound hypertension that can follow the withdrawal of clonidine" type="Specific_Interaction"><Normalization><mmtx cui="C0520540" phraseText="the rebound hypertension" preferredWord="Rebound hypertension" semType="dsyn"/></Normalization></entity><entity charOffset="3:12" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.90.e.5" text="clonidine" type="Drug"><Normalization><mmtx cui="C0009014" phraseText="clonidine" preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><drugClassMembership drug="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.90.e.1" drugClass="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.90.e.0"/><drugInteraction id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.90.ddi.1"><interaction trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.90.e.3"><relations><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.90.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.90.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.90.e.5" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.90.e.0" trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.90.e.3" type="Specific_Interaction"/></sentence><sentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.91" text="If replacing clonidine by beta-blocker therapy, delay the introduction of beta-blockers for several days after clonidine administration has stopped (see Warnings)." type="negative"><entity charOffset="26:38" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.91.e.0" text="beta-blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="replacing clonidine by beta-blocker therapy," preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="13:22" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.91.e.1" text="clonidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0009014" phraseText="replacing clonidine by beta-blocker therapy," preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="74:87" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.91.e.2" text="beta-blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="the introduction of beta-blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="111:120" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.91.e.3" text="clonidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0009014" phraseText="after clonidine administration" preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.91.e.1" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.91.e.0"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.91.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.91.e.3"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.91.e.1" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.91.e.2"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.91.e.2" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.91.e.3"/></sentence><sentence biomedicalEntities="3" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.94" lineNumber="99" text="Alcohol, barbiturates, or narcotics   Potentiation of orthostatic hypotension may occur." type="irregular"><entity charOffset="0:7" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.94.e.0" text="Alcohol" type="Substance"><Normalization><mmtx cui="C0001975" phraseText="Alcohol," preferredWord="Alcohols" semType="phsu, orch"/><RxNorm RxCui="448"/></Normalization></entity><entity charOffset="9:21" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.94.e.1" text="barbiturates" type="Drug_Class"><Normalization><mmtx cui="C0004745" phraseText="barbiturates," preferredWord="Barbiturates" semType="phsu, orch"/><RxNorm RxCui="1437144"/></Normalization></entity><entity charOffset="26:35" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.94.e.2" text="narcotics" type="Drug_Class"><Normalization><mmtx cui="C0027415" phraseText="narcotics   Potentiation of orthostatic hypotension" preferredWord="Narcotics" semType="phsu, hops"/><RxNorm RxCui="992359"/></Normalization></entity><entity charOffset="54:77" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.94.e.3" text="orthostatic hypotension" type="Specific_Interaction"><Normalization><mmtx cui="C0149746" phraseText="narcotics   Potentiation of orthostatic hypotension" preferredWord="Orthostasis" semType="sosy"/></Normalization></entity><drugInteraction id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.94.ddi.1"><interaction trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.94.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.94.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.93" text="When administered concurrently the following drugs may interact with thiazide diuretics:"><entity charOffset="69:87" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.93.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.94.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.94.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.94.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.94.e.1"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.94.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.94.e.2"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.94.e.1" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.94.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.94.e.0"/><pair ddi="true" e1="labelDrug" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.94.e.1"/><pair ddi="true" e1="labelDrug" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.94.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.95" lineNumber="101" text="Antidiabetic drugs (oral agents and insulin)   Dosage adjustment of the antidiabetic drug may be required." type="irregular"><anaphoraRelation><anaphoraEntity charOffset="72:89" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.95.e.1" text="antidiabetic drug" type="Expression"/><antecedentEntity charOffset="0-18" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.95.e.5" text="Antidiabetic drugs" type="SPAN"/></anaphoraRelation><entity charOffset="0:18|20:31" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.95.e.0" text="Antidiabetic drugs oral agents" type="Drug_Class"><Normalization><mmtx cui="C0935929" phraseText="Antidiabetic drugs" preferredWord="Antidiabetics" semType="phsu"/><mmtx cui="C1254351" phraseText="(oral agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="282360"/></Normalization></entity><entity charOffset="47:64" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.95.e.2" text="Dosage adjustment" type="Caution_Interaction"/><entity charOffset="36:43" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.95.e.4" text="insulin" type="Drug"><Normalization><mmtx cui="C0021641" phraseText="insulin" preferredWord="Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1533581" phraseText="insulin" preferredWord="Recombinant Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1579433" phraseText="insulin" preferredWord="Insulin [EPC]" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="0:18" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.95.e.5" text="Antidiabetic drugs" type="SPAN"/><drugInteraction id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.95.ddi.1"><interaction trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.95.e.2"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.93" text="When administered concurrently the following drugs may interact with thiazide diuretics:"><entity charOffset="69:87" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.93.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.94" text="Alcohol, barbiturates, or narcotics   Potentiation of orthostatic hypotension may occur."/></relation><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.95.e.1"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="1" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.96" lineNumber="103" text="Other antihypertensive drugs   Additive effect or potentiation." type="irregular"><entity charOffset="6:28" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.96.e.0" text="antihypertensive drugs" type="Drug_Class"><Normalization><mmtx cui="C0003364" phraseText="Other antihypertensive drugs   Additive effect" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="31:62" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.96.e.1" text="Additive effect or potentiation" type="Increase_Interaction"/><drugInteraction id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.96.ddi.1"><interaction trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.96.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.96.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.93" text="When administered concurrently the following drugs may interact with thiazide diuretics:"><entity charOffset="69:87" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.93.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.94" text="Alcohol, barbiturates, or narcotics   Potentiation of orthostatic hypotension may occur."/><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.95" text="Antidiabetic drugs (oral agents and insulin)   Dosage adjustment of the antidiabetic drug may be required."/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.96.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.97" lineNumber="105" text="Cholestyramine and colestipol resins   Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. " type="regular"><entity charOffset="104:127" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.97.e.0" text="anionic exchange resins" type="Drug_Class"><Normalization><RxNorm RxCui="107801"/></Normalization></entity><entity charOffset="53:72" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.97.e.1" text="hydrochlorothiazide" type="Drug"><Normalization><mmtx cui="C0020261" phraseText="colestipol resins   Absorption of hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="39:49|73:84" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.97.e.2" text="Absorption is impaired" type="Decrease_Interaction"/><drugInteraction id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.97.ddi.1"><interaction trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.97.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.97.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.97.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.97.e.1" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.97.e.0" trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.97.e.2" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.98" lineNumber="105" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively." type="regular"><anaphoraRelation><anaphoraEntity charOffset="99:102" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.98.e.3" text="its" type="Expression"/><antecedentEntity charOffset="68-87" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.98.e.2" text="hydrochlorothiazide" type="Drug"/></anaphoraRelation><entity charOffset="23:37" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.98.e.0" text="cholestyramine" type="Drug"><Normalization><mmtx cui="C0008402" phraseText="Single doses of either cholestyramine" preferredWord="Cholestyramine Resin" semType="phsu, orch"/><RxNorm RxCui="2447"/></Normalization></entity><entity charOffset="41:58" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.98.e.1" text="colestipol resins" type="Drug_Class"><Normalization><mmtx cui="C0009279" phraseText="colestipol resins" preferredWord="Colestipol" semType="phsu, orch"/><RxNorm RxCui="104485"/></Normalization></entity><entity charOffset="68:87" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.98.e.2" text="hydrochlorothiazide" type="Drug"><Normalization><mmtx cui="C0020261" phraseText="the hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="92:98|103:113" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.98.e.5" text="reduce absorption" type="Decrease_Interaction"/><drugInteraction id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.98.ddi.1"><interaction trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.98.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.98.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.98.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.98.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.98.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.98.e.3" trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.98.e.5" type="Decrease_Interaction"/><pair ddi="true" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.98.e.1" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.98.e.3" trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.98.e.5" type="Decrease_Interaction"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.98.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.98.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.99" lineNumber="107" text="Corticosteroids, ACTH   Intensified electrolyte depletion, particularly hypokalemia." type="irregular"><entity charOffset="36:57" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.99.e.0" text="electrolyte depletion" type="Specific_Interaction"/><entity charOffset="72:83" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.99.e.2" text="hypokalemia" type="Specific_Interaction"/><entity charOffset="0:15" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.99.e.4" text="Corticosteroids" type="Drug_Class"><Normalization><mmtx cui="C0001617" phraseText="Corticosteroids," preferredWord="Adrenal Cortex Hormones" semType="strd, phsu, horm"/><RxNorm RxCui="1427675"/></Normalization></entity><entity charOffset="17:21" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.99.e.5" text="ACTH" type="Drug"><Normalization><RxNorm RxCui="376"/></Normalization></entity><drugInteraction id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.99.ddi.1"><interaction trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.99.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.99.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.99.e.4"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.93" text="When administered concurrently the following drugs may interact with thiazide diuretics:"><entity charOffset="69:87" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.93.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.94" text="Alcohol, barbiturates, or narcotics   Potentiation of orthostatic hypotension may occur."/><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.95" text="Antidiabetic drugs (oral agents and insulin)   Dosage adjustment of the antidiabetic drug may be required."/><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.96" text="Other antihypertensive drugs   Additive effect or potentiation."/><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.97" text="Cholestyramine and colestipol resins   Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. "/><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.98" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively."/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.99.ddi.2"><interaction trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.99.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.99.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.99.e.4"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.93" text="When administered concurrently the following drugs may interact with thiazide diuretics:"><entity charOffset="69:87" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.93.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.94" text="Alcohol, barbiturates, or narcotics   Potentiation of orthostatic hypotension may occur."/><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.95" text="Antidiabetic drugs (oral agents and insulin)   Dosage adjustment of the antidiabetic drug may be required."/><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.96" text="Other antihypertensive drugs   Additive effect or potentiation."/><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.97" text="Cholestyramine and colestipol resins   Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. "/><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.98" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively."/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.99.e.4" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.99.e.5"/><pair ddi="true" e1="labelDrug" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.99.e.5"/><pair ddi="true" e1="labelDrug" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.99.e.4"/></sentence><sentence biomedicalEntities="2" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.100" lineNumber="109" text="Pressor amines (eg, norepinephrine)   Possible decreased response to pressor amines but not sufficient to preclude their use." type="irregular"><entity charOffset="0:14" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.100.e.0" text="Pressor amines" type="Drug_Class"><Normalization><mmtx cui="C0237795" phraseText="Pressor amines" preferredWord="Pressors" semType="phsu"/><RxNorm RxCui="203344"/></Normalization></entity><entity charOffset="20:34" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.100.e.1" text="norepinephrine" type="Drug"><Normalization><mmtx cui="C0028351" phraseText="norepinephrine" preferredWord="Norepinephrine" semType="phsu, orch, nsba"/><RxNorm RxCui="7508"/></Normalization></entity><entity charOffset="47:65" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.100.e.3" text="decreased response" type="Decrease_Interaction"/><drugClassMembership drug="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.100.e.1" drugClass="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.100.e.0"/><drugInteraction id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.100.ddi.1"><interaction trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.100.e.3"><relations><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.100.e.0"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.93" text="When administered concurrently the following drugs may interact with thiazide diuretics:"><entity charOffset="69:87" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.93.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.94" text="Alcohol, barbiturates, or narcotics   Potentiation of orthostatic hypotension may occur."/><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.95" text="Antidiabetic drugs (oral agents and insulin)   Dosage adjustment of the antidiabetic drug may be required."/><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.96" text="Other antihypertensive drugs   Additive effect or potentiation."/><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.97" text="Cholestyramine and colestipol resins   Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. "/><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.98" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively."/><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.99" text="Corticosteroids, ACTH   Intensified electrolyte depletion, particularly hypokalemia."/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.101" lineNumber="111" text="Skeletal muscle relaxants, nondepolarizing (eg, tubocurarine)   Possible increased responsiveness to the muscle relaxant." type="irregular"><anaphoraRelation><anaphoraEntity charOffset="105:120" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.101.e.3" text="muscle relaxant" type="Expression"/><antecedentEntity charOffset="0-42" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.101.e.0" text="Skeletal muscle relaxants, nondepolarizing" type="Drug_Class"/></anaphoraRelation><entity charOffset="0:42" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.101.e.0" text="Skeletal muscle relaxants, nondepolarizing" type="Drug_Class"><Normalization><mmtx cui="C0037250" phraseText="Skeletal muscle relaxants," preferredWord="skeletal muscle relaxants" semType="phsu"/><RxNorm RxCui="1427638"/></Normalization></entity><entity charOffset="48:60" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.101.e.1" text="tubocurarine" type="Drug"><Normalization><mmtx cui="C0041345" phraseText="tubocurarine" preferredWord="Tubocurarine" semType="phsu, orch"/><RxNorm RxCui="82115"/></Normalization></entity><entity charOffset="73:97" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.101.e.5" text="increased responsiveness" type="Increase_Interaction"/><drugClassMembership drug="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.101.e.1" drugClass="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.101.e.0"/><drugInteraction id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.101.ddi.1"><interaction trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.101.e.5"><relations><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.101.e.3"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.93" text="When administered concurrently the following drugs may interact with thiazide diuretics:"><entity charOffset="69:87" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.93.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.94" text="Alcohol, barbiturates, or narcotics   Potentiation of orthostatic hypotension may occur."/><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.95" text="Antidiabetic drugs (oral agents and insulin)   Dosage adjustment of the antidiabetic drug may be required."/><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.96" text="Other antihypertensive drugs   Additive effect or potentiation."/><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.97" text="Cholestyramine and colestipol resins   Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. "/><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.98" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively."/><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.99" text="Corticosteroids, ACTH   Intensified electrolyte depletion, particularly hypokalemia."/><middleSentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.100" text="Pressor amines (eg, norepinephrine)   Possible decreased response to pressor amines but not sufficient to preclude their use."/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.102" lineNumber="113" text="Lithium   Generally should not be given with diuretics. " type="regular"><entity charOffset="45:54" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.102.e.0" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="given with diuretics." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="0:7" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.102.e.1" text="Lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="Lithium   Generally" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="27:39" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.102.e.2" text="not be given" type="Caution_Interaction"/><drugInteraction id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.102.ddi.1"><interaction trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.102.e.2"><relations><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.102.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.102.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.102.e.1" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.102.e.0" trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.102.e.2" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.103" lineNumber="113" text="Diuretic agents reduce the renal clearance of lithium and add a high risk of lithium toxicity. " type="regular"><entity charOffset="0:15" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.103.e.0" text="Diuretic agents" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="Diuretic agents" preferredWord="Diuretics" semType="phsu"/><mmtx cui="C1254351" phraseText="Diuretic agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="16:42" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.103.e.1" text="reduce the renal clearance" type="Increase_Interaction"/><entity charOffset="46:53" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.103.e.3" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="the renal clearance of lithium" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="85:93" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.103.e.4" text="toxicity" type="Increase_Interaction"/><entity charOffset="77:84" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.103.e.6" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="a high risk of lithium toxicity." preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.103.ddi.1"><interaction trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.103.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.103.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.103.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.103.ddi.2"><interaction trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.103.e.4"><relations><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.103.e.6"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.103.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.103.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.103.e.3" trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.103.e.1" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.103.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.103.e.6" trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.103.e.4" type="Increase_Interaction"/></sentence><sentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.104" text="Refer to the package insert for lithium preparations before use of such preparations with DUTOPROL." type="negative"><entity charOffset="32:39" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.104.e.0" text="lithium" type="Biomedical_Entity"><Normalization><mmtx cui="C0023870" phraseText="for lithium preparations" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="90:98" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.104.e.1" text="dutoprol" type="Biomedical_Entity"><Normalization><mmtx cui="C3264879" phraseText="with DUTOPROL." preferredWord="Dutoprol" semType="phsu, orch"/><RxNorm RxCui="1372709"/></Normalization></entity><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.104.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.104.e.1"/></sentence><sentence biomedicalEntities="4" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105" lineNumber="115" text="Non-steroidal Anti-inflammatory Drugs   In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium sparing and thiazide diuretics. " type="regular"><entity charOffset="82:119" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.e.0" text="non-steroidal anti-inflammatory agent" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="the administration of a non-steroidal anti-inflammatory agent" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><mmtx cui="C3536840" phraseText="the administration of a non-steroidal anti-inflammatory agent" preferredWord="Nonsteroidal Anti-inflammatory Drug [EPC]" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><entity charOffset="124:143|179:186" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.e.1" text="reduce the diuretic effects" type="Specific_Interaction"/><entity charOffset="124:134|162:186" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.e.3" text="reduce the antihypertensive effects" type="Specific_Interaction"/><entity charOffset="124:134|145:156|179:186" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.e.5" text="reduce the natriuretic effects" type="Specific_Interaction"/><entity charOffset="218:236" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.e.7" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="thiazide diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="190:194|227:236" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.e.8" text="loop diuretics" type="Drug_Class"><Normalization><mmtx cui="C0597277" phraseText="potassium sparing" preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C0012802" phraseText="thiazide diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="104215"/></Normalization></entity><entity charOffset="196:213|227:236" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.e.9" text="potassium sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0597277" phraseText="potassium sparing" preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C0012802" phraseText="thiazide diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="8588"/></Normalization></entity><drugInteraction id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.ddi.1"><interaction trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.e.9"/></relation><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.e.7"/></relation><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.e.8"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.ddi.2"><interaction trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.e.9"/></relation><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.e.7"/></relation><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.e.8"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.ddi.3"><interaction trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.e.9"/></relation><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.e.7"/></relation><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.e.8"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.e.9" trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.e.7" trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.e.8" trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.105.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.106" lineNumber="115" text="Therefore, when DUTOPROL and non-steroidal anti- inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained." type="regular"><entity charOffset="16:24" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.106.e.0" text="DUTOPROL" type="Drug"><Normalization><mmtx cui="C3264879" phraseText="DUTOPROL" preferredWord="Dutoprol" semType="phsu, orch"/><RxNorm RxCui="1372709"/></Normalization></entity><entity charOffset="29:68" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.106.e.1" text="non-steroidal anti- inflammatory agents" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="non-steroidal anti- inflammatory agents" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><entity charOffset="115:123" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.106.e.2" text="observed" type="Caution_Interaction"/><drugInteraction id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.106.ddi.1"><interaction trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.106.e.2"><relations><relation type="hasObject"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.106.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.106.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.106.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.106.e.1" trigger="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.106.e.2" type="Caution_Interaction"/></sentence><sentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.109" text="Carcinogenicity and mutagenicity studies have not been conducted with combinations of metoprolol and hydrochlorothiazide." type="negative"><entity charOffset="86:96" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.109.e.0" text="metoprolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0025859" phraseText="conducted with combinations of metoprolol" preferredWord="Metoprolol" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><entity charOffset="101:120" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.109.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide." preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.109.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.109.e.1"/></sentence><sentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.110" text="A combination of metoprolol tartrate and hydrochlorothiazide produced no adverse effects on the fertility and reproductive performance of male and female rats at doses of up to 200/50 mg/kg/day [about 10 and 20 times the maximum recommended human dose (MRHD) of metoprolol and hydrochlorothiazide, respectively, on a mg/m2 basis]." type="negative"><entity charOffset="262:272" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.110.e.0" text="metoprolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0025859" phraseText="of metoprolol" preferredWord="Metoprolol" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><entity charOffset="41:60" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.110.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="277:296" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.110.e.2" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="323:328" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.110.e.3" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="on a mg/m2 basis" preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><entity charOffset="17:36" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.110.e.4" text="metoprolol tartrate" type="Biomedical_Entity"><Normalization><mmtx cui="C0700548" phraseText="A combination of metoprolol tartrate" preferredWord="Metoprolol Tartrate" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.110.e.1" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.110.e.0"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.110.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.110.e.2"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.110.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.110.e.3"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.110.e.4" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.110.e.0"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.110.e.1" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.110.e.3"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.110.e.4" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.110.e.1"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.110.e.2" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.110.e.3"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.110.e.4" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.110.e.2"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.110.e.4" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.110.e.3"/></sentence><sentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.118" text="All genotoxicity tests performed on metoprolol tartrate (a dominant lethal study in mice, chromosomal studies in somatic cells, a Salmonella/mammalian-microsome mutagenicity test, and a nucleus anomaly test in somatic interphase nuclei) and metoprolol succinate (a Salmonella/mammalian-microsome mutagenicity test) were negative." type="negative"><entity charOffset="113:120" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.118.e.0" text="somatic" type="Biomedical_Entity"><Normalization><mmtx cui="C0702216" phraseText="chromosomal studies in somatic cells," preferredWord="Wallace Brand 3 of Carisoprodol" semType="phsu, orch"/><RxNorm RxCui="985708"/></Normalization></entity><entity charOffset="241:261" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.118.e.1" text="metoprolol succinate" type="Biomedical_Entity"><Normalization><mmtx cui="C0724633" phraseText="metoprolol succinate" preferredWord="metoprolol succinate" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><entity charOffset="210:217" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.118.e.2" text="somatic" type="Biomedical_Entity"><Normalization><mmtx cui="C0702216" phraseText="a nucleus anomaly test in somatic interphase nuclei" preferredWord="Wallace Brand 3 of Carisoprodol" semType="phsu, orch"/><RxNorm RxCui="985708"/></Normalization></entity><entity charOffset="36:55" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.118.e.3" text="metoprolol tartrate" type="Biomedical_Entity"><Normalization><mmtx cui="C0700548" phraseText="performed on metoprolol tartrate" preferredWord="Metoprolol Tartrate" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.118.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.118.e.1"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.118.e.3" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.118.e.0"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.118.e.2" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.118.e.1"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.118.e.3" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.118.e.1"/><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.118.e.3" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.118.e.2"/></sentence><sentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.119" text="No evidence of impaired fertility due to metoprolol tartrate was observed in a study performed in rats at doses up to 22 times, on a mg/m2 basis, the daily dose of 200 mg in a 60 kg patient." type="negative"><entity charOffset="41:60" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.119.e.0" text="metoprolol tartrate" type="Biomedical_Entity"><Normalization><mmtx cui="C0700548" phraseText="due to metoprolol tartrate" preferredWord="Metoprolol Tartrate" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><entity charOffset="139:144" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.119.e.1" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="on a mg/m2 basis," preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.119.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.119.e.1"/></sentence><sentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.126" text="Hydrochlorothiazide had no adverse effects on the fertility of mice and rats of either sex in studies wherein these species were exposed, via their diet, to doses of up to 100 and 4 mg/kg/day (about 20 and 1.6 times the MRHD, on a mg/m2 basis), respectively, prior to mating and throughout gestation." type="negative"><entity charOffset="0:19" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.126.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="237:242" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.126.e.1" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="on a mg/m2 basis" preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.126.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.126.e.1"/></sentence><sentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.131" text="Therapy with any combination of metoprolol succinate extended release and hydrochlorothiazide will be associated with both sets of dose independent side effects. " type="negative"><entity charOffset="74:93" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.131.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="32:52" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.131.e.1" text="metoprolol succinate" type="Biomedical_Entity"><Normalization><mmtx cui="C0724633" phraseText="Therapy with any combination of metoprolol succinate" preferredWord="metoprolol succinate" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.131.e.1" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.131.e.0"/></sentence><sentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.133" text="DUTOPROL may be administered with other antihypertensive agents." type="negative"><entity charOffset="0:8" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.133.e.0" text="dutoprol" type="Biomedical_Entity"><Normalization><mmtx cui="C3264879" phraseText="DUTOPROL" preferredWord="Dutoprol" semType="phsu, orch"/><RxNorm RxCui="1372709"/></Normalization></entity><entity charOffset="40:63" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.133.e.1" text="antihypertensive agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="administered with other antihypertensive agents." preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.133.e.0" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.133.e.1"/></sentence><sentence id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.137" text="Patients usually do not require doses in excess of 50 mg hydrochlorothiazide daily when used concomitantly with other antihypertensive agents." type="negative"><entity charOffset="118:141" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.137.e.0" text="antihypertensive agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="concomitantly with other antihypertensive agents." preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="51:76" id="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.137.e.1" text="50 mg hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0986528" phraseText="doses in excess of 50 mg hydrochlorothiazide daily" preferredWord="Hydrochlorothiazide 50 MG" semType="clnd"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.137.e.1" e2="Dailymed.23ab5537-5d5b-41d6-618c-974930319a48.s.137.e.0"/></sentence><positiveExamples number="25"/><negativeExamples number="98"/></document>